Furthermore, ACPAs purified from RA patient serum can additionally induce NLRP3-dependent IL-1β release from human granulocyte-macrophage colony-stimulating factor-derived macrophages [17]. This evidence concerns the gene NLRP3 and rheumatoid arthritis.